Workboat Indexes

Sanofi-Aventis S.A. ADR (NQ: SNY )

50.81 +0.38 (+0.75%)

Streaming Delayed Price Updated: 11:25 AM EDT, Jul 24, 2024 Add to My Watchlist

Price and Volume

Volume	406,929
Open	50.48
Bid (Size)	50.80 (11)
Ask (Size)	50.82 (12)
Prev. Close	50.43
Today's Range	50.35 - 50.84
52wk Range	42.63 - 55.72
Shares Outstanding	1,250,690,553
Dividend Yield	3.75%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

AstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China Strife

July 23, 2024

The aim is to strengthen their drug pipelines and expand their presence in the world's second-largest pharmaceutical market.

Via Benzinga

European Commission Faces Court Criticism Over COVID Vaccine Contract Transparency Ahead Of Vote on Ursula Von Der Leyen's Reappointment

July 17, 2024

European Commission faces scrutiny over COVID vaccine contract transparency ahead of key vote. Legal challenges and implications discussed.

Via Benzinga

Performance

YTD	+1.62%	+1.62%
1 Month	+3.76%	+3.76%
3 Month	+6.54%	+6.54%
6 Month	+1.84%	+1.84%
1 Year	-5.77%	-5.77%

More News

Stable Blue-Chip Stocks to Buy Before Earnings Season

July 17, 2024

Via InvestorPlace

Senate To Review Novo Nordisk's Levemir Insulin Discontinuation

July 16, 2024

Via Benzinga

Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally

July 21, 2024

Via Benzinga

Sanofi's $20B Consumer Health Unit Sale: Goldman Sachs, Morgan Stanley Line Up $6.5B Financing

July 12, 2024

Via Benzinga

Bernie Sanders Targets High Prices of Ozempic and Wegovy In US

July 11, 2024

Via Benzinga

EXCLUSIVE: VeeCon 2024 Announces Danica Patrick, Jerome Bettis, Paul Scheer, Mike Posner, Liquid Death CEO Mike Cessario As New Speakers

July 11, 2024

Via Benzinga

3 Stocks to Sell Immediately Based on the French Election Results

July 09, 2024

Via InvestorPlace

What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients

July 05, 2024

Via Investor's Business Daily

Upcoming Stock Spinoffs: Should You Pounce or Pass?

July 04, 2024

Via InvestorPlace

7 Safe Haven Stocks to Buy Before the Next Market Correction

July 03, 2024

Via InvestorPlace

Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data

July 03, 2024

Via Benzinga

Novavax’s Second Act: How a Fallen COVID Star Could Rise from the Ashes

July 03, 2024

Via InvestorPlace

Heartburn Drug Zantac Litigation: GSK And Other Pharma Giants Face Trial Over Cancer Claims

July 02, 2024

Via Benzinga

Surprise! 3 Stocks That Are Outperforming Nvidia in 2024.

July 01, 2024

Via InvestorPlace

Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant

July 01, 2024

Via Benzinga

Where Will Novavax Be in 1 Year?

June 29, 2024

Via The Motley Fool

First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product

June 27, 2024

Via Benzinga

Why Is Vigil Neuroscience (VIGL) Stock Up 32% Today?

June 27, 2024

Via InvestorPlace

Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine

June 26, 2024

From Regeneron Pharmaceuticals, Inc.

Via GlobeNewswire

Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC

June 26, 2024

Via Benzinga

Industry Groups Back GSK's Effort To Halt 70,000 Lawsuits Associated With Heartburn Drug Zantac Caused Cancer

June 20, 2024

Via Benzinga

Is It Too Late to Buy Novavax Stock?

June 14, 2024

Via The Motley Fool

Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks

June 13, 2024

Via Investor's Business Daily

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.